Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, Novartis Drugs Fight Rare Pancreatic Tumors in Studies
Bloomberg
Thursday, February 10, 2011 - 9:14am
tags:
Pfizer, Novartis, pancreatic tumors, Sutent, Afinitor
Will Merck Succeed Where Pfizer Did Not?
Seeking Alpha
Thursday, February 10, 2011 - 9:11am
tags:
Pfizer, Merck, CETP inhibitors, Anacetrapib, Torcetrapib
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Motley Fool
Wednesday, February 9, 2011 - 1:14pm
tags:
Amgen, AMG785, denosumab, osteoporosis
Charles River Labs reports 4Q loss on charges
Yahoo/AP
Wednesday, February 9, 2011 - 1:13pm
tags:
earnings, Charles River Laboratories
Targacept starts new trial for diabetes drug
Bizjournals.com
Wednesday, February 9, 2011 - 1:12pm
tags:
diabetes, Targacept, TC-6987
Fosamax judge wants two more bellwethers
Fierce Pharma
Wednesday, February 9, 2011 - 11:57am
tags:
Fosamax, Merck, osteoporosis
Should FDA Hit The Brakes On Accelerated Approval?
Pharmalot
Wednesday, February 9, 2011 - 11:54am
tags:
FDA, Roche, Avastin, breast cancer, Pfizer, AML
Sanofi Quiet on Genzyme Deal
WSJ Online
Wednesday, February 9, 2011 - 11:51am
tags:
M&A, Genzyme, Sanofi
Teva Risks Disappointments as Top Drug Faces Threats
Bloomberg
Wednesday, February 9, 2011 - 11:50am
tags:
Teva Pharmaceuticals, Copaxone, generics, MS, multiple sclerosis
Johnson & Johnson Deal for Crucell Moves Forward
NY Times, NY
Wednesday, February 9, 2011 - 11:49am
tags:
JNJ, vaccines, M&A, Crucell
Obama Health-Care Ruling to Get Speedy Appeals Court Review
Bloomberg
Wednesday, February 9, 2011 - 11:23am
tags:
Obama, healthcare reform
Teva Is Ready for Ratiopharm-Sized Deal, Desheh Says
Bloomberg
Wednesday, February 9, 2011 - 11:22am
tags:
Teva Pharmaceuticals, Ratiopharm, M&A
Teva: Qnaze met goal in perennial allergy study
Yahoo/AP
Wednesday, February 9, 2011 - 11:20am
tags:
Teva Pharmaceuticals, QNAZE, allergies
Sanofi-Aventis sees lower 2011 earnings
Marketwatch
Wednesday, February 9, 2011 - 11:18am
tags:
Sanofi, guidance
Sanofi Profits Fall; Mum on Genzyme
TheStreet.com
Wednesday, February 9, 2011 - 11:18am
tags:
Sanofi, earnings, Genzyme, M&A
FDA Says Drug Firms Didn't Finish Follow-Ups
WSJ Online
Wednesday, February 9, 2011 - 11:16am
tags:
FDA, cancer, Roche, GSK, Eli Lilly, AstraZeneca, Amgen
Ready for the Biotech Century: Where's the Smart Money Going?
Motley Fool
Tuesday, February 8, 2011 - 4:54pm
tags:
biotech, Codexis, Chelsea Therapeutics, EXACT Sciences, Ziopharm
Pfizer Must Pay $1.6 Million Drug Damages, Judges Say
Bloomberg
Tuesday, February 8, 2011 - 4:52pm
tags:
Pfizer, Prempro
The Consensus Opinion on Johnson & Johnson: Bullish
Motley Fool
Tuesday, February 8, 2011 - 4:51pm
tags:
JNJ
Should Pfizer Spin Off Its Nutritional Unit?
Seeking Alpha
Tuesday, February 8, 2011 - 4:50pm
tags:
Pfizer, nutrition

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.